Werken bij Amsterdam UMC

Postdoc- Epigenetics in cellular plasticity and drug resistance of neuroblastoma

Drug resistance is a problem in cancer treatment. We are investigating epigenetic differences and epigenetic modifiers in neuroblastoma cell types. Are you up for a challenge? We have a vacancy!
Postdoc- Epigenetics in cellular plasticity and drug resistance of neuroblastoma
Vragen?
Solliciteer direct
  • Aantal uur: 36 uur per week
  • Specialisme: Laboratoria
  • Contractvorm: bepaalde tijd
  • Salaris: € 2.911 - € 4.615
  • Reageer tot en met: 18 oktober 2021
Solliciteer direct Reageer binnen 1 dag(en)
Wat ga je doen?

We are offering a research position for a highly motivated Postdoc to study the epigenetic differences in neuroblastoma. Neuroblastoma is a pediatric tumor with often a fatal outcome. Primary tumors go in complete remission upon therapy, but relapse as resistant disease. At the department of Oncogenomics we study relapse mechanisms by high throughput-, bioinformatic- and cell biology-  technologies. We found that neuroblastoma consist of two phenotypically divergent types of tumor cells (van Groningen et al., Nature Genetics 2017). They share the same genetic defects and can transdifferentiate into one another. They also have highly divergent epigenetic landscapes, including different super enhancers and core regulatory circuitries. One of the cell types is more therapy-resistant and may cause relapses. In this project funded by the Netherlands Cancer Foundation, we will clarify the epigenetic mechanisms underlying the trans-differentiation between the two cell types and their deregulation in cancer. You will apply screening technologies with in vitro trans-differentiation models, chromatin analyses and protein-protein interactions of chromatin modifiers and collaborate with the bioinformatics team in the for bioinformatic analyses. Effects of drugs intervening with epigenetic modification will be tested.

Vragen over deze functie?
Tanja Hart Tanja Hart +31621603178 Recruitment adviseur
Over het project

Your job

Continuation of a research line funded by the Netherlands Cancer Foundation.

Analyze high-throughput data including RNA-seq, ChIP-seq and whole genome sequencing and extract new ideas.

Set up the protocol and analysis for proteomics related to epigenetic modifiers.

Select and screen epigenetic inhibitors and test in a model system.

Wat neem je mee?

We are looking for an ambitious postdoc with an interest in epigenetic regulation.

You have obtained a PhD in molecular or cancer biology.

You are analytical and creative.

Experience in molecular biology, cell culture and protein-protein interaction techniques is required.

Experience with analysis of high-throughput data (e.g. expression arrays, RNA-seq and ChIP-seq) is an advantage, but we are supported by a strong bioinformatics team (head Dr. Jan Koster)

Good communication skills in English is required.

Wat bieden we jou?
  • A jump start to your career in research work.
  • All te space for you to contribute shaping the care of tomorrow.
  • Working on large-scale and research project, with motivated colleagues from all over the world.
  • We offer a contract for a year (12 months) with the intention to extend for a term with a maximum of the project duration (2 years).
  • Additional benefits include an 8.3% end-of-year bonus and 8.0% holiday pay.
  • The base salary does not include holiday pay (8%) and a year-end bonus (8.3%). 
  • In addition to excellent accessibility by public transport, AMC also has a sufficient number of parking spaces for employees.
  • Pension is accrued at Be Frank.
Waar ga je werken?

The department of Oncogenomics has a long-standing research line in neuroblastoma and collected extensive high throughput data on tumors and cell lines. Research teams focus on cellular re-programming, epigenetics, drug-resistance and bioinformatics. The epigenetic differences between the two neuroblastoma cell phenotypes is the focus of the group of Dr. Linda Valentijn. You will work in this team to study the function of epigenetic modifiers in cellular transition. Combination of hands on research and bioinformatics in the R2 platform (http://r2.amc.nl) allows integration and analysis of data of neuroblastoma and other tissues.

Wat kun je verwachten?
Een baan in onze prachtige hoofdstad
Werken bij de meest favoriete werkgever in de zorg (intermediair 2021)
Alle collega's hebben hetzelfde doel: bijdragen aan de zorg voor morgen
Wij zorgen niet alleen voor onze patiënten, maar ook voor jou
Samenwerking kenmerkt zich door onderling vertrouwen en interesse voor elkaar
Er is ruimte voor ontplooiing, verdieping en verbreding van je kennis
Amsterdam UMC innoveert continu, je moet dus om kunnen gaan met verandering
Op locatie VUmc kun je beperkt parkeren, maar met het OV stap je voor de deur uit
Op locatie AMC is het vaak iets langer lopen naar je werkplek, maar daardoor springt je stappenteller sneller op groen
Een volle agenda, want onze personeelsvereniging organiseert veel leuke activiteiten
Het verhaal van Amsterdam UMC Bekijk de video’s en leer meer over onze organisatie
Amsterdam UMC
Tulp
Verpleegkundige visie
Laten we kennis maken

We look forward to receive your motivation letter and CV!

Preferred start date for this position is as soon as possible.

For more information about this position, you can contact Dr. Linda J. Valentijn, via  l.j.valentijn@amsterdamumc.nl

For more information about the application procedure please contact Tanja Hart, Recruitment Adviser, via T: 06-21603178 or E: t.hart@amsterdamumc.nl

A reference check, screening and hiring test may be part of the procedure. Read hier whether this also applies to you. 

Acquisition in response to this vacancy is not appreciated.